Adverse events associated with apheresis procedures: Incidence and relative frequency
Introduction: Apheresis procedures [Plateletpheresis, Plasmapheresis/ Therapeutic Plasma Exchange (TPE), & Peripheral Blood Stem Cell Collection (PBSC)] are usually well tolerated. Occasionally, Adverse Events (AEs) of variable severity may occur during or after the procedure. AEs that occur in...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2013-01-01
|
Series: | Asian Journal of Transfusion Science |
Subjects: | |
Online Access: | http://www.ajts.org/article.asp?issn=0973-6247;year=2013;volume=7;issue=1;spage=37;epage=41;aulast=Philip |
id |
doaj-edadc8983fd7405489d570f7b05f6c83 |
---|---|
record_format |
Article |
spelling |
doaj-edadc8983fd7405489d570f7b05f6c832020-11-25T00:32:42ZengWolters Kluwer Medknow PublicationsAsian Journal of Transfusion Science0973-62471998-35652013-01-0171374110.4103/0973-6247.106730Adverse events associated with apheresis procedures: Incidence and relative frequencyJoseph PhilipRavi S SarkarAmardeep PathakIntroduction: Apheresis procedures [Plateletpheresis, Plasmapheresis/ Therapeutic Plasma Exchange (TPE), & Peripheral Blood Stem Cell Collection (PBSC)] are usually well tolerated. Occasionally, Adverse Events (AEs) of variable severity may occur during or after the procedure. AEs that occur in Donors/Patients are divided into local reactions and systemic reactions. Materials and Methods: A total of 3,367 apheresis procedures were performed, out of which 3,120 were plateletpheresis procedures, and out of which 1,401 were on Baxter CS 3000 & 1,719 were on Haemonetics MCS+ cell separators. Rest of 247 TPE & PBSC procedures were done on Haemonetics MCS+ cell separators. Results: 90 AEs were reported in relation to the 3,367 procedures. Out of 90 AEs, 85 AEs (94%) were associated with plateletpheresis (n = 3,120) and 05 AEs (06%) with TPE & PBSC (n = 247). The rate of vascular injury (VI), Citrate reaction (CR), and Presyncopal/Syncopal (PS/S) in plateletpheresis was 1.6% (52/3,120), 0.96% (30/3,120), and 0.096% (03/3,120), respectively. The rate of CR in TPE and PBSC was 1.23% (02/162) and 2.3% (02/85), respectively. The rate of PS/S in PBSC was 1.17% (01/85). AEs for Plateletpheresis, TPE & PBSC were 2.7% (85/3,120), 1.23% (02/162), and 3.5% (03/85), respectively. VI, CR, and PS/S were mostly of mild intensity. Both cell separators were equally safe, when AEs associated with plateletpheresis were compared with each other; 2.8% on CS 3000 & 2.6% on MCS+. Conclusion: Apheresis procedures performed on cell separators are safe, with a low incidence of significant AEs. No significant difference was noted in AEs among the two cell separators studied.http://www.ajts.org/article.asp?issn=0973-6247;year=2013;volume=7;issue=1;spage=37;epage=41;aulast=PhilipAdverse eventscitrate reactionperipheral blood stem cellpresyncopal/syncopaltherapeutic plasma exchangevascular injury |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Joseph Philip Ravi S Sarkar Amardeep Pathak |
spellingShingle |
Joseph Philip Ravi S Sarkar Amardeep Pathak Adverse events associated with apheresis procedures: Incidence and relative frequency Asian Journal of Transfusion Science Adverse events citrate reaction peripheral blood stem cell presyncopal/syncopal therapeutic plasma exchange vascular injury |
author_facet |
Joseph Philip Ravi S Sarkar Amardeep Pathak |
author_sort |
Joseph Philip |
title |
Adverse events associated with apheresis procedures: Incidence and relative frequency |
title_short |
Adverse events associated with apheresis procedures: Incidence and relative frequency |
title_full |
Adverse events associated with apheresis procedures: Incidence and relative frequency |
title_fullStr |
Adverse events associated with apheresis procedures: Incidence and relative frequency |
title_full_unstemmed |
Adverse events associated with apheresis procedures: Incidence and relative frequency |
title_sort |
adverse events associated with apheresis procedures: incidence and relative frequency |
publisher |
Wolters Kluwer Medknow Publications |
series |
Asian Journal of Transfusion Science |
issn |
0973-6247 1998-3565 |
publishDate |
2013-01-01 |
description |
Introduction: Apheresis procedures [Plateletpheresis, Plasmapheresis/ Therapeutic Plasma Exchange (TPE), & Peripheral Blood Stem Cell Collection (PBSC)] are usually well tolerated. Occasionally, Adverse Events (AEs) of variable severity may occur during or after the procedure. AEs that occur in Donors/Patients are divided into local reactions and systemic reactions. Materials and Methods: A total of 3,367 apheresis procedures were performed, out of which 3,120 were plateletpheresis procedures, and out of which 1,401 were on Baxter CS 3000 & 1,719 were on Haemonetics MCS+ cell separators. Rest of 247 TPE & PBSC procedures were done on Haemonetics MCS+ cell separators. Results: 90 AEs were reported in relation to the 3,367 procedures. Out of 90 AEs, 85 AEs (94%) were associated with plateletpheresis (n = 3,120) and 05 AEs (06%) with TPE & PBSC (n = 247). The rate of vascular injury (VI), Citrate reaction (CR), and Presyncopal/Syncopal (PS/S) in plateletpheresis was 1.6% (52/3,120), 0.96% (30/3,120), and 0.096% (03/3,120), respectively. The rate of CR in TPE and PBSC was 1.23% (02/162) and 2.3% (02/85), respectively. The rate of PS/S in PBSC was 1.17% (01/85). AEs for Plateletpheresis, TPE & PBSC were 2.7% (85/3,120), 1.23% (02/162), and 3.5% (03/85), respectively. VI, CR, and PS/S were mostly of mild intensity. Both cell separators were equally safe, when AEs associated with plateletpheresis were compared with each other; 2.8% on CS 3000 & 2.6% on MCS+. Conclusion: Apheresis procedures performed on cell separators are safe, with a low incidence of significant AEs. No significant difference was noted in AEs among the two cell separators studied. |
topic |
Adverse events citrate reaction peripheral blood stem cell presyncopal/syncopal therapeutic plasma exchange vascular injury |
url |
http://www.ajts.org/article.asp?issn=0973-6247;year=2013;volume=7;issue=1;spage=37;epage=41;aulast=Philip |
work_keys_str_mv |
AT josephphilip adverseeventsassociatedwithapheresisproceduresincidenceandrelativefrequency AT ravissarkar adverseeventsassociatedwithapheresisproceduresincidenceandrelativefrequency AT amardeeppathak adverseeventsassociatedwithapheresisproceduresincidenceandrelativefrequency |
_version_ |
1725319540704804864 |